Ally Higgins, MD

Medical oncologist at Avera Cancer Institute

[Ally Higgins, MD @allyhigginsmd]

@MakisMD I have read plenty. I am an oncologist. I have seen too many people like you take advantage of vulnerable patients with cancer. Quit posting about patients on standard of care chemo or targeted therapy and claiming the response is from ivermectin.

[Ally Higgins, MD @allyhigginsmd]

@MakisMD Your posts are incredibly misleading. Complete responses are not that surprising with standard treatments for HER2 positive/triple positive breast cancer and triple negative breast cancer.

[Ally Higgins, MD @allyhigginsmd]

@MakisMD So this patient received standard of care chemotherapy and almost achieved a complete response and you’re claiming it’s because of your meds? Standard of care for this type of cancer is a chemo regimen called TCHP which 60% of the time leads to complete pathologic response.

[Ally Higgins, MD @allyhigginsmd]

@MakisMD Shame on you. The BRAF/MEK inhibitor combination this patient was on is the reason for the excellent response. It’s a highly effective treatment for melanoma with certain mutations. He did not have a good response bc of ivermectin/fenbendazole/etc.

[Ally Higgins, MD @allyhigginsmd]

@mpgoetz Disappointed to have missed this! Had to change plans last minute to virtual due to influenza. Next year hopefully!

[Ally Higgins, MD @allyhigginsmd]

@Dr_RShatsky @itsnot_pink @PTarantinoMD Rare, but we just reviewed a patient at our metastatic breast tumor board this morning with a RET fusion so we are excited to be able to offer her this treatment!